Premium
Cannabis and other illicit drug use in epilepsy patients
Author(s) -
Hamerle M.,
Ghaeni L.,
Kowski A.,
Weissinger F.,
Holtkamp M.
Publication year - 2014
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/ene.12081
Subject(s) - cannabis , medicine , epilepsy , odds ratio , illicit drug , cannabidiol , affect (linguistics) , confidence interval , logistic regression , psychiatry , drug , psychology , communication
Background and purpose This study aimed to assess the prevalence of illicit drug use among epilepsy patients and its effects on the disease. Methods We systematically interviewed epilepsy outpatients at a tertiary epilepsy clinic. Predictors for active cannabis use were analysed with a logistic regression model. Results Overall, 310 subjects were enrolled; 63 (20.3%) reported consuming cannabis after epilepsy was diagnosed, and 16 (5.2%) used other illicit drugs. Active cannabis use was predicted by sex (male) [odds ratio ( OR ) 5.342, 95% confidence interval (95% CI ) 1.416–20.153] and age ( OR 0.956, 95% CI 0.919–0.994). Cannabis consumption mostly did not affect epilepsy (84.1%). Seizure worsening was observed with frequent illicit (non‐cannabis) drug use in 80% of cases. Conclusions Cannabis use does not seem to affect epilepsy; however, frequent use of other drugs increases seizure risk.